Finance

Lists
ARVN:NASDAQ
Arvinas Inc
$7.38
-1.14%
(-0.085) 1D
Oct 6, 2:14:30 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ARVN...
Open
$7.49
High
$7.49
Low
$7.29
Mkt. cap
478.99M
Avg. vol.
783.02K
Volume
255.50K
P/E ratio
45.99
52-wk high
$14.51
52-wk low
$6.97
EPS
$0.16
Beta
1.81
Shares outstanding
65.39M
No. of employees
246
Open
$7.49
High
$7.49
Low
$7.29
Mkt. cap
478.99M
Avg. vol.
783.02K
Volume
255.50K
P/E ratio
45.99
52-wk high
$14.51
52-wk low
$6.97
EPS
$0.16
Beta
1.81
Shares outstanding
65.39M
No. of employees
246
News stories
From web sources and news partners
About Arvinas Inc
CEO-
Employees246
Founded2013
HeadquartersNew Haven, Connecticut, United States
SectorPharmaceutical industry
Websitearvinas.com
Analyst ratings
Based on 11 analysts giving stock ratings to ARVN in the past 3 months
Buy
Buy
5
Hold
6
Sell
0
12-month forecast
Based on 11 Wall Street analysts offering 12 month price targets for ARVN in the last 3 months.
Highest
Current $7.38
$21.00 (+184.75%)
Average
$14.96 (+102.85%)
Lowest
$8.68 (+17.69%)
Analyst
Recommendation
Action
Price target
Projected
Date
Edward Tenthoff
Piper Sandler
Buy
Reiterated
$20.00
+171.2%
09/14/2026
Srikripa Devarakonda
Truist Financial
Hold
Reiterated
$8.68
+17.7%
08/10/2026
Terence Flynn
Morgan Stanley
Hold
Reiterated
$10.00
+35.6%
08/10/2026
Jonathan Miller
Evercore ISI
Buy
Reiterated
$14.00
+89.8%
08/10/2026
Yigal Nochomovitz
Citi
Buy
Maintained
$21.00
+184.7%
08/10/2026
Tazeen Ahmad
Bank of America Securities
Hold
Maintained
-
-
08/07/2026
Andrew Fein
H.C. Wainwright
Buy
Maintained
$18.00
+144.1%
08/05/2026
Robert Driscoll
Wedbush
Hold
Maintained
$12.00
+62.7%
08/05/2026
Etzer Darout
Barclays
Buy
Maintained
$20.00
+171.2%
08/05/2026
Nicholas Lorusso
TD Cowen
Hold
Maintained
-
-
08/04/2026
Derek Archila
Wells Fargo
Hold
Downgraded
$11.00
+49.2%
08/05/2026
Unknown Analyst
Leerink Partners
Hold
Maintained
$9.00
+22%
05/15/2026
Paul Choi
Goldman Sachs
Sell
Maintained
$6.00
-18.6%
05/12/2026
Jeet Mukherjee
BTIG
Buy
Reiterated
$18.00
+144.1%
05/13/2026
Tyler Van Buren
TD Cowen
Hold
Maintained
-
-
05/12/2026
Unknown Analyst
Guggenheim
Buy
Maintained
$15.00
+103.4%
05/01/2026
Matthew Biegler
Oppenheimer
Hold
Reiterated
-
-
02/26/2026
Sudan Loganathan
Stephens
Buy
Maintained
$18.00
+144.1%
02/25/2026
Last report
Aug 4, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
$2.58 / -$0.28
+1,012.37%beat
Revenue / Est. (USD)
249.70M / 60.69M
+311.46%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
41.90M
9.50M
15.60M
249.70M
Cost of goods sold
-
-
60.00M
9.00M
Cost of revenue
-
-
60.00M
9.00M
Research and development expenses
64.30M
59.80M
-
52.30M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
21.60M
21.40M
18.80M
22.70M
Operating expense
85.90M
81.20M
18.80M
75.00M
Total operating expenses
85.90M
81.20M
78.80M
84.00M
Operating income
-44.00M
-71.70M
-63.20M
165.70M
Other non operating income
-
2.40M
-100.00K
-
EBT including unusual items
-34.80M
-67.20M
-57.50M
169.60M
EBT excluding unusual items
-35.00M
-61.90M
-56.90M
171.20M
Income tax expense
300.00K
200.00K
100.00K
200.00K
Effective tax rate
-0.86%
-0.30%
-0.17%
0.12%
Other operating expenses
-
-
-
-
Net income
-35.10M
-67.40M
-57.60M
169.40M
Net profit margin
-83.77%
-709.47%
-369.23%
67.84%
Earnings per share
-0.48
-1.10
-0.90
2.58
Interest and investment income
9.00M
7.40M
6.40M
5.50M
Interest expense
-
-
-
-
Net interest expenses
9.00M
7.40M
6.40M
5.50M
Depreciation and amortization charges
-
-
-
-
EBITDA
-43.20M
-71.00M
-62.50M
166.40M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps